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Abstract: Recent observations suggest the presence of an interaction between leptin and 
the inflammatory system during bronchial asthma. Although there is evidence of a positive 
association between asthma and obesity in adults and children, little is yet known about 
the role of serum leptin, as a potential mediator for bronchial epithelial homeostasis, and 
intraleukocyte myeloperoxidase (MPO), a hemoprotein with a molecular weight of 140 kDa, 
expression of the inflammatory system, in asthmatic children. Glycemic tolerance is an impor-
tant pathogenetic element in developing type 2 mellitus diabetes and a confirmed predictor 
of incident asthma-like symptoms in adults. This work is aimed at assessing a possible cor-
relation between basal leukocyte myeloperoxidase levels, basal leptin and insulin-glycemic 
tolerance in obese children. Thirty obese children aged between 7 and 15 years were exam-
ined. The analyzed data showed a normal response to the insulinemic stimulus in children of 
both sexes whose basal leptin and MPO values, expressed as MPO intracellular index, were 
within the normal range.
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Background
Recent observations suggest the presence of an interaction between leptin and 
the inflammatory system during bronchial asthma.1,2 Leptin, the hormone mainly 
synthesized by adipose tissue, is involved in a complex network of neurotrasmitters 
that modulate appetite. Many tissues produce leptin: the placenta syncytial trophoblast, 
the gastric fundus mucosa, skeletal muscle tissue and hypophysis. Most of leptin, 
however, is produced in adipose tissue. Leptin’s role is mainly to regulate food intake, 
but it also has a number of other metabolic functions: it stimulates macrophages and 
neutrophils, it has an antiapoptotic activity on various cell types, and it regulates T-cell 
proliferation. The production/suppression of leptin plasma levels is mainly related to 
the quantity of adipocytes, but also to various endocrinological factors, the main one 
being insulin levels. The lower the insulin levels, the lower the leptin synthesis. Low 
insulin levels are in fact typical indicators of hunger. Other factors that stimulate leptin 
secretion are: adrenergic stimuli, growth hormone (GH) and thyroid hormones such 
as triiodothyronine and inflammatory stimuli.
The leptin-producing obese (OB) gene is located on chromosome 7 and has 
three exons and two introns. The OB gene transcription can be regulated by response 
elements, such as sequences of nucleotides to which transcription factors bind (such 
as the cAMP Response Element [CRE]).3–5Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 114
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Recent observations suggest the presence of an interaction 
between leptin and the inflammatory system. However, there 
is no adequate knowledge about the role of leptin in atopic 
states, such as bronchial asthma.2 Although there is evidence 
of a positive association between asthma and obesity in adults 
and children, little is yet known about the role of leptin in 
asthmatic children: the findings suggest that leptin may 
play a role in atopic asthma, prevailing in postadolescent 
male children and in asthmatic boys. Insulin resistance (IR) 
is a confirmed predictor of incident asthma-like symptoms 
in adults and leptin is potentially a mediator for bronchial 
epithelial homeostasis: decreased expression of leptin/leptin 
receptor characterizes severe asthma and is associated with 
airway remodelling features.6–9
Myeloperoxidase (MPO) is a hemoprotein with a 
molecular weight of 140 kDa, and is made of two light 
subunits weighing 15 kDa. Each MPO molecule contains 
two porphyrins that play a fundamental role in the catalytic 
cycle. MPO is firstly found in the grains of neutrophils and 
eosinophils. It has a bactericidal potential since it catalyzes 
the production of hypochlorous acid, a potent oxidant 
generated by the reaction of chloride ion with hydrogen 
peroxide, which has a significant pro-inflammatory action 
and contributes directly to tissue damage. The expression of 
leptin receptors on eosinophils has recently shown that leptin 
can be considered a survival cytokine for human neutrophils 
and eosinophils and has a relevant potential role to play in 
allergic and inflammatory diseases.
Study aim
This work aims to verify through a retrospective study, the 
following personal observations: whether the relationship 
between obesity and asthma are mediated by an inflammatory 
state as measured by elevated leptin and leukocyte MPO levels 
in obese children, and by studying glycemic tolerance, which 
is an early sign of diabetes mellitus and associated IR.
Methods
Thirty obese children (15 males and 15 females with body 
mass index [BMI]  30), without bronchial asthma symp-
toms, aged between 7 and 15 years were examined. Informed 
consent was obtained according to the criteria of the Helsinki 
Treaty.
Glucose tolerance in these patients was analyzed by 
providing them with a stimulus: they were administered 
1.75 g of glucose/Kg and the response was assessed at 
times 0, 60, and 120 min. Leptin was evaluated using 
ELISA – Technogenetics (Milan, Italy). MPO of neutrophil 
Table 1 Biochemical test values and MPXI values in normal 
response
CRP 0.0 ± 0.4 (n.v. 0.0–0.5 mg%)
fT3 3.2 ± 1.1 (n.v. 1.62–5.52 pg/mL)
fT4 1.3 ± 0–9 (n.v. 0.74–2.04 ng/mL)
TSH 2.9 ± 0.5 (n.v. 0.25–4.6 mU/L)
Leptin 7.6 ± 3.1 (n.v. 1.64–13.32 mg%)
MPXI 4 ± 2.0 (n.v. –10 + 10)
Abbreviations: CRP, C-reactive protein; fT, free thyroxine; MPXI, intracel-
lular mean peroxidase index; TSH, thyroid-stimulating hormone.
Table 2 Biochemical test and MPXI values in pathological 
response
CRP 0.0 ± 0.4 (n.v. 0.0–0.5 mg%)
fT3 2.3 ± 1.0 (n.v. 1.62–5.52 pg/mL)
fT4 1.7 ± 0.6 (n.v. 0.74–2.04 ng/dL)
TSH 3.4 ± 0.6 (n.v. 0.25–4.6 mU/L)
Leptin 16.3 ± 4.5 (n.v. 1.64–13.32 mg%)
MPXI 12 ± 7 (n.v. –10 + 10)
Abbreviations: CRP, C-reactive protein; fT, free thyeroxine; MPXI, intracel-
lular mean peroxidase index; TSH, thyroid-stimulating hormone.
and eosinophil counts were analyzed with ADVIA 120 
automated analyzer as myeloperoxidase intracellular 
index (MPXI), a parameter derived from the mean position 
on the axis of an archetypal population of neutrophils and 
eosinophils: cells absorb light in proportion to the amount of 
colored peroxidase that is present (reported on x-axis) and 
spread light in proportion to their size (reported on y-axis). 
This whole blood automated method is certified and devel-
oped to assess eosinophil and neutrophil activity in terms of 
peroxidase content and cell morphology.
All subjects had an MPXI greater than -10 to ensure that 
no case of MPO deficiency was included.
The level of C-reactive protein (CRP) as an inflammation 
index was determined in all the patients and control tests on 
thyroid functionality, were performed by Modular P1 – Roche 
(Geneva, Switzerland) to exclude other simultaneous corre-
lated pathologies (Tables 1 and 2). The BMI values for the 
children aged 7–15 years were 31.4 ± 2.7 kg/m?.
Results
The analyzed data showed a normal response to the 
insulinemic stimulus in children of both sexes whose 
basal leptin and MPXI values were within the normal 
range. (Figures 1 and 2). Pathological stimulus-related 
values were correlated to high basal leptin and MPXI levels Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 115
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(Figures 3 and 4). MPXI and leptin are directly correlated 
one with the other (P  0.001). The CRP results and other 
main thyroid tests were in the normal range.
Discussion
MPXI for subjects of the same group of age, without asthma 
symptoms, but with obesity and normal range of basal 
glucose, are defined in the literature.16,17
Many evidences show a correlation between obesity and 
increased risk of bronchial asthma. Altered GT and IR are 
believed to play an significant role in asthma, although precise 
data are not available.10–15 IR is, after all, a common condition 
in many multifactorial diseases such as obesity and type 2 
diabetes. The presence of a common inflammatory factor may 
explain the relationship between GT, IR, and asthma. Leptin 
is known to be one of these factors. A high MPXI could be 
another contributing factor that may have to be assessed when 
directly correlated with leptin. Our experience has shown 
that high MPO and leptin levels are indicative of an altered 
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Figure 2 Insulin levels (µUI/mL) after oral glucose tolerance test in normal response.
Our work is aimed at proposing the determination of 
leukocyte MPXI when analyzing basal leptin and serum 
glucose. This test is included in the hemochrome-cytometric 
exam and does not entail any extra costs. Associated high 
levels of MPXI and leptin in obese children may suggest an 
altered response to the oral glucose load and to be predic-
tion of asthma.
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Figure 3 Glucose (mg%) after oral glucose tolerance test in pathological response.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3
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